Times are changing, and we are changing in them. An old saying that goes back to Ovid - but still true today. The business world has become more VUCA (volatile, uncertain, complex, ambiguous) than ever.
Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.
Newsletter & e-edition
News, trends and background information as well as the latest issue of CHEManager International